Marks Group Wealth Management Inc Sells 9,324 Shares of Stryker Corporation $SYK

Marks Group Wealth Management Inc lowered its position in shares of Stryker Corporation (NYSE:SYK) by 21.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,733 shares of the medical technology company’s stock after selling 9,324 shares during the period. Stryker makes up approximately 1.1% of Marks Group Wealth Management Inc’s portfolio, making the stock its 16th largest position. Marks Group Wealth Management Inc’s holdings in Stryker were worth $11,413,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Godfrey Financial Associates Inc. purchased a new stake in Stryker during the 4th quarter valued at $26,000. Sankala Group LLC bought a new position in shares of Stryker during the fourth quarter valued at $26,000. United Financial Planning Group LLC bought a new position in shares of Stryker during the third quarter valued at $27,000. Atlas Capital Advisors Inc. purchased a new stake in shares of Stryker during the fourth quarter valued at $27,000. Finally, DJE Kapital AG bought a new stake in Stryker in the 4th quarter worth about $28,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Sanford C. Bernstein set a $410.00 target price on shares of Stryker in a research note on Friday, May 1st. Argus set a $370.00 price objective on shares of Stryker in a report on Thursday, July 9th. Weiss Ratings downgraded shares of Stryker from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, May 4th. Wall Street Zen cut shares of Stryker from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Finally, BMO Capital Markets started coverage on shares of Stryker in a research report on Wednesday, July 8th. They issued an “outperform” rating and a $369.00 target price for the company. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $392.52.

Insider Buying and Selling

In other Stryker news, VP Robert S. Fletcher sold 4,544 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the sale, the vice president owned 10,582 shares in the company, valued at approximately $3,247,298.34. This trade represents a 30.04% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Ronda E. Stryker sold 310,000 shares of Stryker stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the transaction, the director directly owned 1,924,880 shares in the company, valued at $601,005,282.40. This represents a 13.87% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 323,264 shares of company stock valued at $100,659,489. 4.60% of the stock is owned by company insiders.

Stryker Trading Up 1.7%

Stryker stock opened at $316.46 on Thursday. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $404.87. The company has a market cap of $121.32 billion, a P/E ratio of 36.63, a P/E/G ratio of 1.99 and a beta of 0.77. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. The business has a 50-day simple moving average of $311.28 and a two-hundred day simple moving average of $337.10.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing the consensus estimate of $2.98 by ($0.38). The business had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.Stryker’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter last year, the company earned $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Analysts predict that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be paid a $0.88 dividend. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio is 40.74%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.